References
- Åstedt B. No cross reaction between circulating plasminogen activator and urokinase. Thromb. Res 1979; 14: 535
- Åstedt B. Immunological detection of tumour plasminogen activator in vitro and in vivo. Biological Markers of Neoplasia: Basic and Applied Aspects, R. W. Ruddon. Elsevier North Hoiianu Inc., New York 19783; 481
- Astedt B., Holmberg L. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature 1976; 261: 595
- Astedt B., Wallén P., Aasted P. Occurrence of both urokinase and tissue plasmmogen activator in human seminal plasma. Thromb. Res 1979; 16: 463
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem 1952; 40: 346
- Barret A. J., Starkey P. M., Munn E. A. The unique nature of the interaction of α2--macro-globulin with proteinases. Bayer Symposium V 'Proteinase Inhibitors', H. Fritz, H. Tschesche, L. J. Greene, E. Truscheit. Springer-Verlag, Berlin, Heidelberg, New York 19743
- Bernik M. B., Kwaan H. C. Origin of fibrinolytic activity in cultures of the human kidney. J. Lab. clin. Med 1967; 70: 650
- Boyde T. R.C., Pryme J. F. α2--macroglobulin bincling of trypsin, chymotrypsin, papain and cationic aspartate aminotransferase. Clinica chim. Acta 1968; 21: 9
- Clemmensen I., Christensen F. Inhibition of urokinase by complex formation with αl-antitrypsin. Biochim. Biophys. Acta 1976; 429: 591
- Collen Billiau D. A., Edy J., de Somer P. Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells. Biochim. Biophys. Acta 1977; 499: 194
- Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095
- Ganrot P. O. Crossed immuno electrophoresis. Scand. J. clin. Lab. Invest 1972; 29(7), suppl. 124
- Harpel P. C. Studies on human plasma α2--macro-globulin-enzyme interactions. J. exp. Med 1973; 138: 508
- Holmberg L., Bladh B., Åstedt B. Purification of urokinase by affinity chromatography. Biochim. biophys. Acta 1976; 445: 215
- Holmberg L., Lecander I., Persson B., Åstedt B. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim. Biophys. Acta 1978; 544: 128
- Johansson B. G. Agarose gel electrophoresis. Scand. J. Clin. Lab. Invest 1972; 29(7), suppl. 124
- Moroi M., Aoki N. Isolation and characterization of α2--plasmin inhibitor from human plasma. J. biol. Chem 1976; 251: 5956
- Nilsson I. M., Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand 1962; 123: 247
- Painter R. H., Charles A. F. Characterization of a soluble plasminogen activator from kidney cell cultures. Am. J. Physiol 1962; 202: 1125
- Thorell J. I., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim. biophys. Acta 1971; 251: 363
- Vahtera E., Hamberg U. Absence of bincling of pancreatic and urinary kallikreins to α2--macro-globulin. Biochim. J 1976; 157: 521
- Vahtera E., Hamberg U. Interaction of urokinase with α2:macroglobulin' investigated by isoelectric focusing. Biochem. J 1978; 171: 767
- Vetterlein D., Young P. L., Bell T. E., Roblin R. Immunological characterization of multiple molecular weight forms of human cell plasminogen activators. J. biol. Chem 1979; 254: 575
- Wu M.-C., Arimura G. K., Yunis A. A. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 1977; 16: 1908